Which first-generation antipsychotics should be “repurposed” for the treatment of schizophrenia Stefan LeuchtJohn M. Davis Editorial Open access 17 January 2022 Pages: 1 - 3
Clinical characterization of brief psychotic disorders triggered by the COVID-19 pandemic: a multicenter observational study María José Valdés-FloridoÁlvaro López-DíazMiguel Ruiz-Veguilla Original Paper 03 April 2021 Pages: 5 - 15
The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia Gregory P. StraussKelsey I. MacdonaldSydney H. James Original Paper 21 April 2021 Pages: 17 - 27
Evolution of psychosocial burden and psychiatric symptoms in patients with psychiatric disorders during the Covid-19 pandemic Michael BelzPhilipp HessmannClaudia Bartels Original Paper Open access 03 May 2021 Pages: 29 - 40
Neurological and psychiatric presentations associated with COVID-19 Xudong HeDan ZhangXingyue Hu Original Paper 12 March 2021 Pages: 41 - 52
The impact of COVID-19-related distress on levels of depression, anxiety and quality of life in psychogeriatric patients Carolin MiklitzChristine WesterteicherKlaus Fliessbach Original Paper 13 October 2021 Pages: 53 - 66
Differential psychological response to the COVID-19 pandemic in psychiatric inpatients compared to a non-clinical population from Germany Stephanie V. RekDaniel FreemanFrank Padberg Original Paper Open access 15 July 2021 Pages: 67 - 79
Two-stage mental health survey of first-line medical staff after ending COVID-19 epidemic assistance and isolation Li XuDingyun YouJianzhong Yang Original Paper Open access 18 May 2021 Pages: 81 - 93
Hospital workforce mental reaction to the pandemic in a low COVID-19 burden setting: a cross-sectional clinical study Panagiotis AlexopoulosDimitrios RoukasAntonios Politis Original Paper 27 April 2021 Pages: 95 - 105
Online therapy: an added value for inpatient routine care? Perspectives from mental health care professionals Julia SanderFelix BolinskiGabriel Gerlinger Original Paper 16 March 2021 Pages: 107 - 118
Social isolation and psychosis: an investigation of social interactions and paranoia in daily life Anne-Kathrin J. FettEsther HanssenSukhi S. Shergill Original Paper Open access 15 June 2021 Pages: 119 - 127
Universal healthcare coverage for first episode of schizophrenia-spectrum disorders in Chile: analysis of the administrative database Verónica LarachLuis F. VarelaMatías Irarrázaval Original Paper 26 March 2021 Pages: 129 - 138
Cognitive decline following acute viral infections: literature review and projections for post-COVID-19 Rodolfo Furlan DamianoBruno F. GuedesOrestes Forlenza Invited Review 25 June 2021 Pages: 139 - 154
Postural sway and neurocognition in individuals meeting criteria for a clinical high-risk syndrome K. Juston OsborneVijay A. Mittal Short Communication 19 February 2021 Pages: 155 - 160
Old drug fluvoxamine, new hope for COVID-19 Yaeko HashimotoTakuji SuzukiKenji Hashimoto Letter to the Editor 02 September 2021 Pages: 161 - 163
The weaker sex? What we can learn from sex differences in population mental health during and beyond the COVID-19 pandemic Katrin Elisabeth GielBirgit Derntl Letter to the Editor Open access 29 July 2021 Pages: 165 - 166
The link between Toxoplasma gondii infections and higher mortality in COVID-19 patients having schizophrenia Kevin Roe Letter to the Editor 04 October 2021 Pages: 167 - 168
Pain management and prevention of suicide in the COVID-19 era Soroush Pakniyat-JahromiLeo Sher Letter to the Editor 05 March 2021 Pages: 169 - 170
Correction to: Lateralization of increased density of Iba1-immunopositive microglial cells in the anterior midcingulate cortex of schizophrenia and bipolar disorder Elisabeth Petrasch-ParwezAndreas SchöbelGeorg Juckel Correction Open access 12 October 2021 Pages: 171 - 171